-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on aTyr Pharma, Maintains $35 Price Target

Benzinga·03/14/2025 10:48:52
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis reiterates aTyr Pharma (NASDAQ:ATYR) with a Buy and maintains $35 price target.